Gold Nanoparticle-Mediated Delivery of siRNA: A Promising Strategy in the Treatment of Mosquito-Borne Viral Diseases?

References

• Paul AM , ShiY , AcharyaDet al. Delivery of anti-viral siRNA with gold-nanoparticles inhibits dengue virus infection in vitro . J. Gen. Virol.8 , 1712 – 1722 ( 2014 ).
   Google Scholar
• Davis ME , ChenZG , ShinDM . Nanoparticle therapeutics: an emerging treatment modality for cancer . Nat. Rev. Drug Discov.7 ( 9 ), 771 – 782 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Zheng D , GiljohannDA , ChenDLet al. Topical delivery of siRNA-based spherical nucleic acid nanoparticle conjugates for gene regulation . Proc. Natl Acad. Sci. USA109 ( 30 ), 11975 – 11980 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Heinz FX , StiasnyK . Flaviviruses and flavivirus vaccines . Vaccine30 ( 29 ), 4301 – 4306 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Ikegami T , MakinoS . Rift valley fever vaccines . Vaccine27 ( Suppl. 4 ), D69 – D72 ( 2009 ).
   PubMedGoogle Scholar
• Go YY , BalasuriyaUB , LeeCK . Zoonotic encephalitides caused by arboviruses: transmission and epidemiology of alphaviruses and flaviviruses . Clin. Exp. Vaccine Res.3 ( 1 ), 58 – 77 ( 2014 ).
   PubMedGoogle Scholar
• Thiboutot MM , KannanS , KawalekarOUet al. Chikungunya: a potentially emerging epidemic? PLoS Negl. Trop. Dis. 4 ( 4 ), e623 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Gao K , HuangL . Nonviral methods for siRNA delivery . Mol. Pharm.6 ( 3 ), 651 – 658 ( 2009 ).
   PubMedGoogle Scholar
• Gilstrap K , HuX , LuX , HeX . Nanotechnology for energy-based cancer therapies . Am. J Cancer Res.1 ( 4 ), 508 – 520 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Hunter AC , MoghimiSM . Cationic carriers of genetic material and cell death: a mitochondrial tale . Biochim. Biophys. Acta1797 ( 6–7 ), 1203 – 1209 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Zintchenko A , PhilippA , DehshahriA , WagnerE . Simple modifications of branched PEI lead to highly efficient siRNA carriers with low toxicity . Bioconjug. Chem.19 ( 7 ), 1448 – 1455 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Huang F , ShiY . Synthesis of symmetrical thiol-adenosine conjugate and 5′ thiol-RNA preparation by efficient one-step transcription . Bioorg. Med. Chem. Lett.20 ( 21 ), 6254 – 6257 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Stein DA , PerryST , BuckMDet al. Inhibition of dengue virus infections in cell cultures and in AG129 mice by a small interfering RNA targeting a highly conserved sequence . J. Virol.85 ( 19 ), 10154 – 10166 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Wang X , YuB , RenWet al. Enhanced hepatic delivery of siRNA and microRNA using oleic acid based lipid nanoparticle formulations . J. Control. Release172 ( 3 ), 690 – 698 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Zimmermann TS , LeeAC , AkincAet al. RNAi-mediated gene silencing in non-human primates . Nature441 ( 7089 ), 111 – 114 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Zhong YQ , WeiJ , FuYRet al. [Toxicity of cationic liposome Lipofectamine 2000 in human pancreatic cancer Capan-2 cells] . Nan Fang Yi Ke Da Xue Xue Bao28 ( 11 ), 1981 – 1984 ( 2008 ).
   PubMedGoogle Scholar
• Conde J , TianF , HernandezYet al. In vivo tumor targeting via nanoparticle-mediated therapeutic siRNA coupled to inflammatory response in lung cancer mouse models . Biomaterials34 ( 31 ), 7744 – 7753 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Goel R , SwanlundD , CoadJ , PaciottiGF , BischofJC . TNF-alpha-based accentuation in cryoinjury – dose, delivery, and response . Mol. Cancer Ther.6 ( 7 ), 2039 – 2047 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Goel R , ShahN , VisariaR , PaciottiGF , BischofJC . Biodistribution of TNF-alpha-coated gold nanoparticles in an in vivo model system . Nanomedicine (Lond.)4 ( 4 ), 401 – 410 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Libutti SK , PaciottiGF , ByrnesAAet al. Phase I and pharmacokinetic studies of CYT-6091, a novel PEGylated colloidal gold-rhTNF nanomedicine . Clin. Cancer Res.16 ( 24 ), 6139 – 6149 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Dobrovolskaia MA , AggarwalP , HallJB , McneilSE . Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution . Mol. Pharm.5 ( 4 ), 487 – 495 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Zhang XD , WuD , ShenXet al. Size-dependent in vivo toxicity of PEG-coated gold nanoparticles . Int. J. Nanomed.6 , 2071 – 2081 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Liu J , YuM , ZhouC , YangS , NingX , ZhengJ . Passive tumor targeting of renal-clearable luminescent gold nanoparticles: long tumor retention and fast normal tissue clearance . J. Am. Chem. Soc.135 ( 13 ), 4978 – 4981 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Lasagna-Reeves C , Gonzalez-RomeroD , BarriaMAet al. Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice . Biochem. Biophys. Res. Commun.393 ( 4 ), 649 – 655 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Sadauskas E , DanscherG , StoltenbergM , VogelU , LarsenA , WallinH . Protracted elimination of gold nanoparticles from mouse liver . Nanomedicine5 ( 2 ), 162 – 169 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Lewinski N , ColvinV , DrezekR . Cytotoxicity of nanoparticles . Small4 ( 1 ), 26 – 49 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Cho WS , ChoM , JeongJet al. Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles . Toxicol. Appl. Pharmacol.236 ( 1 ), 16 – 24 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Connor EE , MwamukaJ , GoleA , MurphyCJ , WyattMD . Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity . Small1 ( 3 ), 325 – 327 ( 2005 ).
   PubMed Web of Science ®Google Scholar